156 related articles for article (PubMed ID: 34265397)
1. Calcium channel TRPV6 promotes breast cancer metastasis by NFATC2IP.
Xu X; Li N; Wang Y; Yu J; Mi J
Cancer Lett; 2021 Oct; 519():150-160. PubMed ID: 34265397
[TBL] [Abstract][Full Text] [Related]
2. Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor-negative breast cancer.
Peters AA; Simpson PT; Bassett JJ; Lee JM; Da Silva L; Reid LE; Song S; Parat MO; Lakhani SR; Kenny PA; Roberts-Thomson SJ; Monteith GR
Mol Cancer Ther; 2012 Oct; 11(10):2158-68. PubMed ID: 22807578
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen inhibits TRPV6 activity via estrogen receptor-independent pathways in TRPV6-expressing MCF-7 breast cancer cells.
Bolanz KA; Kovacs GG; Landowski CP; Hediger MA
Mol Cancer Res; 2009 Dec; 7(12):2000-10. PubMed ID: 19996302
[TBL] [Abstract][Full Text] [Related]
4. TRPV6 calcium channel directs homeostasis of the mammary epithelial sheets and controls epithelial mesenchymal transition.
Kärki T; Rajakylä EK; Acheva A; Tojkander S
Sci Rep; 2020 Sep; 10(1):14683. PubMed ID: 32895467
[TBL] [Abstract][Full Text] [Related]
5. Regulation of calcium influx and signaling pathway in cancer cells via TRPV6-Numb1 interaction.
Kim SY; Yang D; Myeong J; Ha K; Kim SH; Park EJ; Kim IG; Cho NH; Lee KP; Jeon JH; So I
Cell Calcium; 2013 Feb; 53(2):102-11. PubMed ID: 23140583
[TBL] [Abstract][Full Text] [Related]
6. Auto-inhibitory intramolecular S5/S6 interaction in the TRPV6 channel regulates breast cancer cell migration and invasion.
Cai R; Wang L; Liu X; Michalak M; Tang J; Peng JB; Chen XZ
Commun Biol; 2021 Aug; 4(1):990. PubMed ID: 34413465
[TBL] [Abstract][Full Text] [Related]
7. The role of TRPV6 in breast carcinogenesis.
Bolanz KA; Hediger MA; Landowski CP
Mol Cancer Ther; 2008 Feb; 7(2):271-9. PubMed ID: 18245667
[TBL] [Abstract][Full Text] [Related]
8. TRPV6 calcium channel translocates to the plasma membrane via Orai1-mediated mechanism and controls cancer cell survival.
Raphaël M; Lehen'kyi V; Vandenberghe M; Beck B; Khalimonchyk S; Vanden Abeele F; Farsetti L; Germain E; Bokhobza A; Mihalache A; Gosset P; Romanin C; Clézardin P; Skryma R; Prevarskaya N
Proc Natl Acad Sci U S A; 2014 Sep; 111(37):E3870-9. PubMed ID: 25172921
[TBL] [Abstract][Full Text] [Related]
9. RNA interference mediated suppression of TRPV6 inhibits the progression of prostate cancer
Kim DY; Kim SH; Yang EK
Investig Clin Urol; 2021 Jul; 62(4):447-454. PubMed ID: 34085788
[TBL] [Abstract][Full Text] [Related]
10. ADAMTS6 suppresses tumor progression via the ERK signaling pathway and serves as a prognostic marker in human breast cancer.
Xie Y; Gou Q; Xie K; Wang Z; Wang Y; Zheng H
Oncotarget; 2016 Sep; 7(38):61273-61283. PubMed ID: 27542224
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer.
Song H; Dong M; Zhou J; Sheng W; Li X; Gao W
Oncol Rep; 2018 Mar; 39(3):1432-1440. PubMed ID: 29344675
[TBL] [Abstract][Full Text] [Related]
12. Suppression of aberrant transient receptor potential cation channel, subfamily V, member 6 expression in hyperproliferative colonic crypts by dietary calcium.
Peleg S; Sellin JH; Wang Y; Freeman MR; Umar S
Am J Physiol Gastrointest Liver Physiol; 2010 Sep; 299(3):G593-601. PubMed ID: 20508153
[TBL] [Abstract][Full Text] [Related]
13. Heavy metal cations permeate the TRPV6 epithelial cation channel.
Kovacs G; Danko T; Bergeron MJ; Balazs B; Suzuki Y; Zsembery A; Hediger MA
Cell Calcium; 2011 Jan; 49(1):43-55. PubMed ID: 21146870
[TBL] [Abstract][Full Text] [Related]
14. TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways.
Lehen'kyi V; Flourakis M; Skryma R; Prevarskaya N
Oncogene; 2007 Nov; 26(52):7380-5. PubMed ID: 17533368
[TBL] [Abstract][Full Text] [Related]
15. Structural bases of TRP channel TRPV6 allosteric modulation by 2-APB.
Singh AK; Saotome K; McGoldrick LL; Sobolevsky AI
Nat Commun; 2018 Jun; 9(1):2465. PubMed ID: 29941865
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal positive regulation between TRPV6 and NUMB in PTEN-deficient prostate cancer cells.
Kim SY; Hong C; Wie J; Kim E; Kim BJ; Ha K; Cho NH; Kim IG; Jeon JH; So I
Biochem Biophys Res Commun; 2014 Apr; 447(1):192-6. PubMed ID: 24704446
[TBL] [Abstract][Full Text] [Related]
17. TRPV6 determines the effect of vitamin D3 on prostate cancer cell growth.
Lehen'kyi V; Raphaël M; Oulidi A; Flourakis M; Khalimonchyk S; Kondratskyi A; Gordienko DV; Mauroy B; Bonnal JL; Skryma R; Prevarskaya N
PLoS One; 2011 Feb; 6(2):e16856. PubMed ID: 21347289
[TBL] [Abstract][Full Text] [Related]
18. TRPV6 potentiates calcium-dependent cell proliferation.
Schwarz EC; Wissenbach U; Niemeyer BA; Strauss B; Philipp SE; Flockerzi V; Hoth M
Cell Calcium; 2006 Feb; 39(2):163-73. PubMed ID: 16356545
[TBL] [Abstract][Full Text] [Related]
19. RGS2 inhibits the epithelial Ca2+ channel TRPV6.
Schoeber JP; Topala CN; Wang X; Diepens RJ; Lambers TT; Hoenderop JG; Bindels RJ
J Biol Chem; 2006 Oct; 281(40):29669-74. PubMed ID: 16895908
[TBL] [Abstract][Full Text] [Related]
20. TRPV6 channels.
Fecher-Trost C; Weissgerber P; Wissenbach U
Handb Exp Pharmacol; 2014; 222():359-84. PubMed ID: 24756713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
